Trond Undheim, PhD, Program Director, MIT Startup Exchange; Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT; Laura Indolfi, PhD, CEO of PanTher Therapeutics; Peter Sandor, VP, Head of Oncology Marketing Strategy, Astellas.
David Shrier, CEO & founder, Distilled Identity
Hear from distinguished MIT faculty and startups on topics such as recent advances in precision medicine for a more targeted and personalized treatment, immunotherapy to fight cancer cells, gene therapy, AI to improve diagnosis, treatment, and patient outcomes, and more.
Dr. Cory Kidd, Founder & CEO, Catalia Health
Investing in the Drivers of the Future of Energy, Ben Sampson, Director, Energy, GE Ventures
Christina Qi, Partner, Domeyard LP
Dilip Sundaram - Corporate Keynote